VHL mutation leads to the accumulation of HIF1α and/or HIF2α even in normoxia [6], however, it has been well-established that HIF2α, but not HIF1α, is the critical oncogenic substrate of VHL in ccRCC [7–9]. The gene discussed is EPAS1; the disease is nonpapillary renal cell carcinoma.